These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36990922)

  • 1. Barriers in translating stem cell therapies for neonatal diseases.
    Damianos A; Sammour I
    Semin Perinatol; 2023 Apr; 47(3):151731. PubMed ID: 36990922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stromal/Stem Cell Extracellular Vesicles and Perinatal Injury: One Formula for Many Diseases.
    Delavogia E; Ntentakis DP; Cortinas JA; Fernandez-Gonzalez A; Alex Mitsialis S; Kourembanas S
    Stem Cells; 2022 Nov; 40(11):991-1007. PubMed ID: 36044737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell therapy for intractable neonatal disorders.
    Ahn SY; Park WS; Sung SI; Chang YS
    Pediatr Neonatol; 2021 Feb; 62 Suppl 1():S16-S21. PubMed ID: 33485822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges.
    Chang YS; Ahn SY; Sung S; Park WS
    Yonsei Med J; 2017 Mar; 58(2):266-271. PubMed ID: 28120555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cells for Neonatal Brain Disorders.
    Ahn SY; Chang YS; Park WS
    Neonatology; 2016; 109(4):377-83. PubMed ID: 27251746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem Cell Therapy in Neonatal Diseases.
    Gheorghe CP; Bhandari V
    Indian J Pediatr; 2015 Jul; 82(7):637-41. PubMed ID: 25804318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the therapeutic potential of the stem cell secretome in neonatal diseases.
    Tung S; Delavogia E; Fernandez-Gonzalez A; Mitsialis SA; Kourembanas S
    Semin Perinatol; 2023 Apr; 47(3):151730. PubMed ID: 36990921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental tissue stem cells and their role in neonatal diseases.
    Damianos A; Xu K; Kalin GT; Kalinichenko VV
    Semin Fetal Neonatal Med; 2022 Feb; 27(1):101322. PubMed ID: 34953760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell therapy for neonatal hypoxic-ischemic encephalopathy.
    Pimentel-Coelho PM; Mendez-Otero R
    Stem Cells Dev; 2010 Mar; 19(3):299-310. PubMed ID: 19916801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases.
    Wang Y; Long W; Cao Y; Li J; You L; Fan Y
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32320046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.
    Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy.
    Pierro M; Ciarmoli E; Thébaud B
    Clin Perinatol; 2015 Dec; 42(4):889-910. PubMed ID: 26593085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing Brain Damage from Hypoxic-Ischemic Encephalopathy in Neonates: Update on Mesenchymal Stromal Cells and Umbilical Cord Blood Cells.
    Nabetani M; Mukai T; Shintaku H
    Am J Perinatol; 2022 Dec; 39(16):1754-1763. PubMed ID: 33853147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia.
    O'Reilly M; Thébaud B
    Clin Perinatol; 2012 Sep; 39(3):703-25. PubMed ID: 22954277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Applications of Extracellular Vesicles: Perspectives from Newborn Medicine.
    Willis GR; Kourembanas S; Mitsialis SA
    Methods Mol Biol; 2017; 1660():409-432. PubMed ID: 28828676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia.
    Namba F
    Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Good things come in small packages": application of exosome-based therapeutics in neonatal lung injury.
    Willis GR; Mitsialis SA; Kourembanas S
    Pediatr Res; 2018 Jan; 83(1-2):298-307. PubMed ID: 28985201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation.
    Lesage F; Thébaud B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.